Iol Chemicals And Pharmaceuticals Limited (IOLCP)
ISIN: - Industry: Drug Manufacturers—Specialty & Generic Sector: Healthcare Website
382.9
23.9(6.66%)

IOL Chemicals and Pharmaceuticals Limited manufactures and sells pharmaceutical and chemical products in India and internationally. The company offers active pharmaceutical ingredients (API), such as ibuprofen, ibuprofen lysinate, ibuprofen sodium, and dex- ibuprofen; and other APIs, including metformin hydrochloride, clopidogrel bisulphate, pantoprazole sodium, ursodeoxycholic acid, losartan potassium, gabapentin, levetiracetam, lamotrigine, and fenofibrate. Its products are used for treatments, which include anti-inflammatory, analgesic and antipyretic, anti-diabetic, anti- platelet, anti-cholesterol, anti- convulsant, anti-cholelithic, as well as proton pump inhibitor. The company also provides specialty industrial chemicals comprising ethyl acetate, iso butyl benzene, acetyl chloride, and mono chloro acetic acid for use in food processing, flexible packaging, pharmaceuticals, textiles, ink, paint, pesticides, and chemical intermediates industries. IOL Chemicals and Pharmaceuticals Limited was incorporated in 1986 and is headquartered in Ludhiana, India.

Pricing Updates

TODAY'S HIGH

393.8

TODAY'S LOW

359

52 WEEK HIGH

624

52 WEEK LOW

292.8

Major Holders

% of Shares Held by
All Insider

64.22%

% of Shares Held by
Institutions

2.11%

% of Float Held by
Institutions

5.89%

Number of Institutions
Holding Shares

13

Company Overview

MARKET CAP

2247.83 Cr.

ETERPRISE VALUE

2002.06 Cr.

NO. OF SHARES

5.87 Cr.

BOOK VALUE

237.163

DIV. YIELD

4%

DEBT

43.95 Cr.

GROSS PROFIT

602.80 Cr.

CASH

120.06 Cr.

REVENUE

2230.52 Cr.

REVENUE/SHARE

380.043

OHLC Chart 1y 2y 5y 10y

Price Chart

1d 1w 1m 3m 6m 1Yr 2Yr 5Yr

Volumes Chart

1d 1w 1m 3m 6m 1Yr 2Yr 5Yr

Cashflows

ParticularsMar 2022Mar 2021Mar 2020Mar 2019
Investments-1.14 Cr.-221.23 Cr.-102.67 Cr.-102.67 Cr.
Change To Liabilities183.19 Cr.60.61 Cr.51.80 Cr.-18.33 Cr.
Total cashflows from Investing Activities-120.19 Cr.-317.25 Cr.-184.23 Cr.-63.04 Cr.
Net Borrowings41.69 Cr.-57.05 Cr.-229.60 Cr.-120.82 Cr.
Total Cash from Financing Activities-1.64 Cr.-58.28 Cr.-271.89 Cr.-197.46 Cr.
Other Liabilities0000
Total Assets0006 Cr.
Net Income167.67 Cr.444.56 Cr.361.29 Cr.236.70 Cr.
Change in Cash-28.78 Cr.4.25 Cr.14.68 Cr.12.67 Cr.
Effect of Exchange Rate0000
Total Cash from Operating Activities93.05 Cr.379.78 Cr.470.80 Cr.273.17 Cr.
Depreciation43.26 Cr.38.82 Cr.35.61 Cr.32.32 Cr.
Other Cashflows from Investing Activities32.35 Cr.11.41 Cr.-1.88 Cr.-3.27 Cr.
Dividends Paid-35.22 Cr.-23.48 Cr.-17.07 Cr.-17.07 Cr.
Change to Inventory-114.75 Cr.-107.62 Cr.1.34 Cr.18.59 Cr.
Change to Account Receivables-170.78 Cr.-29.50 Cr.-50.36 Cr.-77.90 Cr.
Other Cashflows from Financing Activities-8.11 Cr.22.25 Cr.-25.22 Cr.-82.64 Cr.
Change to Net Income-15.54 Cr.-27.19 Cr.71 Cr.81.66 Cr.
Capital Expenditures-153.29 Cr.-108.21 Cr.-80.28 Cr.-60.53 Cr.

Financials

ParticularsMar 2022Mar 2021Mar 2020Mar 2019
Research DevelopmentNoneNoneNoneNone
Effect of Accounting ChargesNoneNoneNoneNone
Income Before Tax224.85 Cr.571.39 Cr.533.24 Cr.336.15 Cr.
Minority InterestNoneNoneNoneNone
Net Income215.03 Cr.553.07 Cr.538.16 Cr.377.22 Cr.
Selling General Administrative141.30 Cr.115.69 Cr.97.35 Cr.79.37 Cr.
Gross Profit613.51 Cr.857.34 Cr.820.73 Cr.632.10 Cr.
Ebit215.03 Cr.553.07 Cr.538.16 Cr.377.22 Cr.
Operating Income215.03 Cr.553.07 Cr.538.16 Cr.377.22 Cr.
Other Operating Expenses213.92 Cr.149.66 Cr.149.49 Cr.143.06 Cr.
Interest Expense-8.29 Cr.-94 Lakhs-16.01 Cr.-46.65 Cr.
Extraordinary ItemsNoneNoneNoneNone
Non RecurringNoneNoneNoneNone
Other ItemsNoneNoneNoneNone
Income Tax Expense57.18 Cr.126.83 Cr.171.95 Cr.99.45 Cr.
Total Revenue2184.02 Cr.1966.98 Cr.1894.47 Cr.1685.33 Cr.
Total Operating Expenses1968.99 Cr.1413.91 Cr.1356.31 Cr.1308.11 Cr.
Cost of Revenue1570.51 Cr.1109.64 Cr.1073.74 Cr.1053.23 Cr.
Total Other Income Expense Net9.82 Cr.18.32 Cr.-4.92 Cr.-41.07 Cr.
Discontinued OperationsNoneNoneNoneNone
Net Income from Continuous Ops.167.67 Cr.444.56 Cr.361.29 Cr.236.70 Cr.
Net Income Applicable to Common Shares167.67 Cr.444.56 Cr.361.29 Cr.236.70 Cr.

Balance Sheet

ParticularsMar 2022Mar 2021Mar 2020Mar 2019
Intangible Assets3.35 Cr.21 Lakhs35 Lakhs58 Lakhs
Capital Surplus0225.72 Cr.190.27 Cr.190.27 Cr.
Total Liabilities570.02 Cr.349.66 Cr.356.25 Cr.467.54 Cr.
Stock Holder Equity1392.28 Cr.1260.43 Cr.813.54 Cr.474.34 Cr.
Minority Interest0000
Other Liabilities60.34 Cr.24.22 Cr.18.86 Cr.25.54 Cr.
Total Assets1962.30 Cr.1610.09 Cr.1169.79 Cr.941.88 Cr.
Common Stock58.71 Cr.58.71 Cr.56.89 Cr.56.89 Cr.
Retained Earnings0971.31 Cr.550.23 Cr.209.51 Cr.
Other Liabilities56.44 Cr.57.28 Cr.77 Cr.20.77 Cr.
Good Will0000
Treasury Stock1333.57 Cr.4.69 Cr.16.15 Cr.17.67 Cr.
Other Assets10.30 Cr.7.49 Cr.10.76 Cr.18.86 Cr.
Cash139.99 Cr.32.34 Cr.28.09 Cr.13.41 Cr.
Current Liabilities513.40 Cr.290.55 Cr.276.52 Cr.256.89 Cr.
Long Term Asset Charges0000
Short Long Term Debt007 Lakhs26.40 Cr.
Other Stockholder Equity1333.57 Cr.4.69 Cr.16.15 Cr.17.67 Cr.
Property Plant Equipment662.49 Cr.560.42 Cr.487.88 Cr.438.16 Cr.
Total Cur. Assets1080.82 Cr.1022.29 Cr.670.80 Cr.484.28 Cr.
Long Term Investments205.34 Cr.19.68 Cr.00
Net Tangible Assets1388.93 Cr.1260.22 Cr.813.19 Cr.473.76 Cr.
Short Term Investments2.37 Cr.304.08 Cr.102.67 Cr.0
Net Receivables493.69 Cr.333.98 Cr.292.07 Cr.202.18 Cr.
Long Term Debt000189.88 Cr.
Inventory409.89 Cr.295.15 Cr.187.52 Cr.188.86 Cr.
Accounts Payable409.29 Cr.238.83 Cr.180.38 Cr.120.27 Cr.

New Offers


Upstox offer
Upstox

Open a demat account through us and get the account opening charges waived off

open paperless account